Literature DB >> 27401134

Influence of parity and sexual history on cytomegalovirus seroprevalence among women aged 20-49 years in the USA.

Tatiana M Lanzieri1, Deanna Kruszon-Moran2, Manoj Gambhir3, Stephanie R Bialek4.   

Abstract

OBJECTIVE: To assess the influence of parity, as a proxy for exposure to children, and sexual history on cytomegalovirus (CMV) seroprevalence.
METHODS: Data were retrospectively analyzed from women aged 20-49 years who were tested for CMV immunoglobulin G antibodies in the 1999-2004 National Health and Nutrition Examination Survey, a nationally representative survey of the US population. Logistic regression was used to determine independent variables associated with CMV seroprevalence.
RESULTS: Among 3710 women, the age-adjusted CMV seroprevalence was 61.3% (95% CI 58.9%-63.6%). In age-adjusted univariate analysis, women who had given birth at least once had higher overall CMV seroprevalence (66.0%, 95% CI 63.1%-68.9%) than did those who had not given birth (49.0%, 95% CI 44.4%-53.7%; P<0.001). In multivariate logistic analysis, higher CMV seroprevalence was independently associated with number of live births (each additional birth: adjusted odds ratio [aOR] 1.2, 95% CI 1.1-1.3), age at first sexual intercourse (<18 vs ≥18years: aOR 1.3, 95% CI 1.1-1.6), lifetime sexual partners (≥10 vs <10: aOR 1.4, 95% CI 1.1-1.9), and herpes type 2 seropositivity (aOR 1.9, 95% CI 1.5-2.6) after controlling for age, race/Hispanic origin, place of birth, poverty index, and education.
CONCLUSION: Among US women of reproductive age, parity and sexual exposures were independently associated with increased CMV seroprevalence. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Cytomegalovirus; Parity; Reproductive age; Seroprevalence

Mesh:

Substances:

Year:  2016        PMID: 27401134      PMCID: PMC5042139          DOI: 10.1016/j.ijgo.2016.03.032

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  21 in total

1.  Interval between births and risk of congenital cytomegalovirus infection.

Authors:  Karen B Fowler; Sergio Stagno; Robert F Pass
Journal:  Clin Infect Dis       Date:  2004-03-15       Impact factor: 9.079

2.  Births in the United States, 2014.

Authors:  Joyce A Martin; Brady E Hamilton; Michelle J K Osterman
Journal:  NCHS Data Brief       Date:  2015-09

3.  Cytomegalovirus seroprevalence in French pregnant women: parity and place of birth as major predictive factors.

Authors:  B Gratacap-Cavallier; J L Bosson; P Morand; N Dutertre; B Chanzy; P S Jouk; C Vandekerckhove; P Cart-Lamy; J M Seigneurin
Journal:  Eur J Epidemiol       Date:  1998-02       Impact factor: 8.082

4.  Maternal immunity and prevention of congenital cytomegalovirus infection.

Authors:  Karen B Fowler; Sergio Stagno; Robert F Pass
Journal:  JAMA       Date:  2003-02-26       Impact factor: 56.272

5.  Influence of sexual activity on cytomegalovirus seroprevalence in the United States, 1988-1994.

Authors:  Stephanie A S Staras; W Dana Flanders; Sheila C Dollard; Robert F Pass; John E McGowan; Michael J Cannon
Journal:  Sex Transm Dis       Date:  2008-05       Impact factor: 2.830

6.  Maternal age and congenital cytomegalovirus infection: screening of two diverse newborn populations, 1980-1990.

Authors:  K B Fowler; S Stagno; R F Pass
Journal:  J Infect Dis       Date:  1993-09       Impact factor: 5.226

7.  Cytomegalovirus prevalence in pregnant women: the influence of parity.

Authors:  P A Tookey; A E Ades; C S Peckham
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

8.  Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population.

Authors:  Aparecida Yulie Yamamoto; Marisa Marcia Mussi-Pinhata; Suresh B Boppana; Zdenek Novak; Virginia M Wagatsuma; Patricia de Frizzo Oliveira; Geraldo Duarte; William J Britt
Journal:  Am J Obstet Gynecol       Date:  2010-01-13       Impact factor: 8.661

9.  Modeling the potential impact of vaccination on the epidemiology of congenital cytomegalovirus infection.

Authors:  Tatiana M Lanzieri; Stephanie R Bialek; Ismael R Ortega-Sanchez; Manoj Gambhir
Journal:  Vaccine       Date:  2014-05-14       Impact factor: 3.641

10.  Cytomegalovirus reinfections in healthy seroimmune women.

Authors:  Shannon A Ross; Nitin Arora; Zdenek Novak; Karen B Fowler; William J Britt; Suresh B Boppana
Journal:  J Infect Dis       Date:  2010-02-01       Impact factor: 5.226

View more
  5 in total

1.  Natural Inhibitor of Human Cytomegalovirus in Human Seminal Plasma.

Authors:  Sina Lippold; Berenike Braun; Franziska Krüger; Mirja Harms; Janis A Müller; Rüdiger Groß; Jan Münch; Jens von Einem
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

2.  Effect of Breastfeeding and Additional Household Children on Cytomegalovirus Seroprevalence among U.S. Children 1 to 5 Years of Age.

Authors:  Susanna Schmink; Deanna Kruszon-Moran; Sheila C Dollard; Tatiana M Lanzieri
Journal:  Clin Vaccine Immunol       Date:  2017-11-06

3.  Cytomegalovirus seroprevalence, recurrence, and antibody levels: Associations with cadmium and lead exposures in the general United States population.

Authors:  Catherine M Bulka; Paige A Bommarito; Allison E Aiello; Rebecca C Fry
Journal:  Environ Epidemiol       Date:  2020-06-05

4.  The convergent epidemiology of tuberculosis and human cytomegalovirus infection.

Authors:  Frank Cobelens; Nico Nagelkerke; Helen Fletcher
Journal:  F1000Res       Date:  2018-03-06

5.  Assessment of Congenital Cytomegalovirus Prevalence Among Newborns in Minnesota During the COVID-19 Pandemic.

Authors:  Mark R Schleiss; Sondra Rosendahl; Mark McCann; Sheila C Dollard; Tatiana M Lanzieri
Journal:  JAMA Netw Open       Date:  2022-09-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.